Naobios receives $1.87M (€1.7M) in support of vaccine development

11 December 2023
Our members

Nantes, France, December 11, 2023 – Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, today announces the receipt of a $1.87M (€1.7M) grant from the Bill & Melinda Gates Foundation in support of vaccine development. Naobios will manufacture a human viral challenge agent that will be used to evaluate the effectiveness of vaccines in preventing infections and to accelerate the vaccine development process. To know more